RT Journal Article
SR Electronic
T1 Differentials in the characteristics of COVID-19 cases in Wave-1 and Wave-2 admitted to a network of hospitals in North India
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.24.21259438
DO 10.1101/2021.06.24.21259438
A1 Budhiraja, Sandeep
A1 Indrayan, Abhaya
A1 Aggarwal, Mona
A1 Jha, Vinita
A1 Jain, Dinesh
A1 Tarai, Bansidhar
A1 Das, Poonam
A1 Aggarwal, Bharat
A1 Mishra, RS
A1 Bali, Supriya
A1 Mahajan, Monica
A1 Nangia, Vivek
A1 Lall, Ajay
A1 Kishore, Nevin
A1 Jain, Ashish
A1 Singh, Omender
A1 Singh, Namrita
A1 Kumar, Ashok
A1 Saxena, Prashant
A1 Dewan, Arun
A1 Aggarwal, Ritesh
A1 Sahay, Shailesh
A1 Dang, Rajiv
A1 Mishra, Neelima
A1 Mathur, Mohit
A1 Chugh, I. M.
A1 Aneja, Pankaj
A1 Dhall, Sanjay
A1 Boobna, Vandana
A1 Arora, Vinit
A1 Gupta, Ajay
A1 Arora, Vijay
A1 Mehra, Mukesh
A1 Jain, Meenakshi
A1 Nakra, Vimal
A1 Sharma, BD
A1 Pandey, Praveen
A1 Singh, YP
A1 Vardani, Anil
A1 Singal, RK
A1 Pandey, Deepak Gargi
A1 Bhasin, Atul
A1 Nayyar, Sandeep
A1 Pande, Rajesh
A1 Chaudhary, Pankaj
A1 Gupta, Ajay Kr
A1 Gupta, Ashish
A1 Tayal, Nitesh
A1 Gupta, Puneet
A1 Gupta, Manish
A1 Khetrapal, Sumit
A1 Pandove, Sachin
A1 Bhasin, Deepak
A1 Midha, Devender
A1 Singh, Harpal
A1 Dixit, Ambrish
A1 Sagar, Vinay
A1 Chachra, Vaibhav
A1 Uniyal, Bhupesh
A1 Saxena, Sanjay
A1 Singh, Amarjit
A1 Sharma, Shalini
YR 2021
UL http://medrxiv.org/content/early/2021/06/27/2021.06.24.21259438.abstract
AB Second wave of COVID-19 pandemic in India came with unexpected quick speed and intensity, creating an acute shortage of beds, ventilators, and oxygen at the peak of occurrence. This may have been partly caused by emergence of new variant delta. Clinical experience with the cases admitted to hospitals suggested that it is not merely a steep rise in cases but also possibly the case-profile is different. This study was taken up to investigate the differentials in the characteristics of the cases admitted in the second wave versus those admitted in the first wave.Records of a total of 14398 cases admitted in the first wave (2020) to our network of hospitals in north India and 5454 cases admitted in the second wave (2021) were retrieved, making it the largest study of this kind in India. Their demographic profile, clinical features, management, and outcome was studied.Age-sex distribution of the cases in the second wave was not much different from those admitted in the first wave but the patients with comorbidities and those with greater severity had larger share. Level of inflammatory markers was more adverse. More patients needed oxygen and invasive ventilation. ICU admission rate remained nearly the same. On the positive side, readmissions were lower, and the duration of hospitalization was slightly less. Usage of drugs like remdesivir and IVIG was higher while that of favipiravir and tocilizumab was lower. Steroid and anticoagulant use remained high and almost same during the two waves. More patients had secondary bacterial and fungal infections in Wave-2. Mortality increased by almost 40% in Wave-2, particularly in the younger patients of age less than 45 years. Higher mortality was observed in those admitted in wards, ICU, with or without ventilator support and those who received convalescent plasma.No significant demographic differences in the cases in these two waves, indicates the role of other factors such as delta variant and late admissions in higher severity and more deaths. Comorbidity and higher secondary bacterial and fungal infections may have contributed to increased mortality.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any financial contribution from any funding agency/source.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Institutional Ethics Committee Max Super Speciality Hospital (A unit of Devki Devi Foundation) address : Service Floor Office of Ethics Committee East Block next to Conference Room Max Super Speciality Hospital Saket (A unit of Devki Devi Foundation) 2 Press Enclave Road, Saket, New Delhi 110017 vide ref. no. BHR/RS/MSSH/DDF/SKT-2/IEC/IM/21-15 dated 23rd June2021. The IEC provided no objection and approval for the publication of above manuscript.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the admitted patients data taken from EHR.